These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 2450890

  • 1. Histological origins of discordant chorionic gonadotropin secretion in malignancy.
    Hay DL.
    J Clin Endocrinol Metab; 1988 Mar; 66(3):557-64. PubMed ID: 2450890
    [Abstract] [Full Text] [Related]

  • 2. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M, Berkowitz R, Goldstein D, Bellet D, Wands JR.
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [Abstract] [Full Text] [Related]

  • 3. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C, Goto S, Furuhashi Y, Tomoda Y.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [Abstract] [Full Text] [Related]

  • 4. Human chorionic gonadotropin and free subunits' serum levels in patients with partial and complete hydatidiform moles.
    Berkowitz R, Ozturk M, Goldstein D, Bernstein M, Hill L, Wands JR.
    Obstet Gynecol; 1989 Aug; 74(2):212-6. PubMed ID: 2473429
    [Abstract] [Full Text] [Related]

  • 5. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 6. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 8. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 9. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA, Butler S.
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [Abstract] [Full Text] [Related]

  • 10. Human chorionic gonadotropin, its free subunits and gestational trophoblastic disease.
    Ozturk M.
    J Reprod Med; 1991 Jan; 36(1):21-6. PubMed ID: 1706779
    [Abstract] [Full Text] [Related]

  • 11. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 12. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE, Sweep FC, Schijf CP, Massuger LF, Thomas CM.
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K.
    Gynecol Obstet Invest; 1987 Oct; 23(3):151-6. PubMed ID: 3036671
    [Abstract] [Full Text] [Related]

  • 14. Serum progesterone monitoring in post-molar surveillance.
    Vasilev SA, Schlaerth JB, Ahn C, Sauer MV.
    Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
    [Abstract] [Full Text] [Related]

  • 15. Comparison of human chorionic gonadotropin regression in molar pregnancies and post-molar nonmetastatic gestational trophoblastic neoplasia.
    Rotmensch J, Rosenshein NB, Block BS.
    Gynecol Oncol; 1988 Jan; 29(1):82-6. PubMed ID: 2448190
    [Abstract] [Full Text] [Related]

  • 16. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P, Leyendecker G.
    Arch Gynecol; 1979 Jul 20; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract] [Full Text] [Related]

  • 17. [Monitoring hCG and its subunits in patients with choriocarcinoma].
    Vlachová J, Skrivan J, RůzkováM, Jakoubková J, Zavadil M, Polák J.
    Cesk Gynekol; 1984 Sep 20; 49(8):559-63. PubMed ID: 6209023
    [No Abstract] [Full Text] [Related]

  • 18. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
    Dawood MY, Saxena BB, Landesman R.
    Obstet Gynecol; 1977 Aug 20; 50(2):172-81. PubMed ID: 195242
    [Abstract] [Full Text] [Related]

  • 19. Elevated sera levels of SP-1 induced by chemotherapy in patients with metastatic gestational trophoblastic diseases.
    Göcze PM, Than GN, Szabò DG, Csaba IF, Bohn H.
    Oncology; 1990 Aug 20; 47(5):406-9. PubMed ID: 1699189
    [Abstract] [Full Text] [Related]

  • 20. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R.
    Gynecol Oncol; 2006 Aug 20; 102(2):160-4. PubMed ID: 16631918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.